Smith & Nephew SNATS Revenue 2006-2019 | SNN

Smith & Nephew SNATS annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Smith & Nephew SNATS revenue for the quarter ending June 30, 2019 was $M, a NAN% increase year-over-year.
  • Smith & Nephew SNATS revenue for the twelve months ending June 30, 2019 was $0M, a NAN% increase year-over-year.
  • Smith & Nephew SNATS annual revenue for 2018 was $4.904B, a 2.92% increase from 2017.
  • Smith & Nephew SNATS annual revenue for 2017 was $4.765B, a 2.06% increase from 2016.
  • Smith & Nephew SNATS annual revenue for 2016 was $4.669B, a 0.76% increase from 2015.
Smith & Nephew SNATS Annual Revenue
(Millions of US $)
2018 $4,904
2017 $4,765
2016 $4,669
2015 $4,634
2014 $4,617
2013 $4,351
2012 $4,137
2011 $4,270
2010 $3,962
2009 $3,772
2008 $3,801
2007 $3,369
2006 $2,779
2005 $2,562
Smith & Nephew SNATS Quarterly Revenue
(Millions of US $)
Q2 2019
Q4 2018
Q2 2018
Q4 2017
Q2 2017
Q4 2016
Q4 2015
Q2 2015
Q4 2014 $1,249
Q3 2014 $1,148
Q2 2014 $1,147
Q1 2014 $1,073
Q4 2013 $1,175
Q3 2013 $1,027
Q2 2013 $1,074
Q1 2013 $1,075
Q4 2012 $1,077
Q3 2012 $952
Q2 2012 $1,029
Q1 2012 $1,079
Q4 2011 $1,106
Q3 2011 $1,032
Q2 2011 $1,077
Q1 2011 $1,055
Q4 2010 $1,067
Q3 2010 $941
Q2 2010 $959
Q1 2010 $995
Q4 2009 $1,066
Q3 2009 $915
Q2 2009 $926
Q1 2009 $865
Q4 2008 $960
Q3 2008 $930
Q2 2008 $1,000
Q1 2008 $911
Q4 2007 $967
Q3 2007 $845
Q2 2007 $813
Q1 2007 $744
Q4 2006 $771
Q3 2006 $679
Q2 2006 $686
Q1 2006 $643
Q4 2005 $673
Q3 2005 $609
Q2 2005 $652
Q1 2005 $625
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $20.228B $4.904B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $152.706B 27.85
Medtronic (MDT) Ireland $152.160B 21.02
Stryker (SYK) United States $75.917B 25.53
Boston Scientific (BSX) United States $62.848B 29.66
Baxter (BAX) United States $42.866B 25.99
Essilor Luxottica (ESLOY) France $34.245B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.456B 19.11
Terumo (TRUMY) Japan $27.092B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.394B 0.00
Coloplast (CLPBY) Denmark $24.797B 38.27
ResMed (RMD) United States $22.090B 40.75
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Insulet (PODD) United States $10.859B 516.62
Bio-Rad Laboratories (BIO) United States $10.615B 50.95
William Demant Holdings (WILYY) Denmark $7.675B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
Perrigo (PRGO) Ireland $7.340B 13.69
Hill-Rom Holdings (HRC) United States $7.289B 21.49
Canopy Growth (CGC) Canada $7.208B 0.00
Haemonetics (HAE) United States $5.904B 39.89
Shandong Weigao Medical Polymer (SHWGF) China $5.472B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.947B 31.08
ICU Medical (ICUI) United States $3.686B 24.03
Neogen (NEOG) United States $3.583B 59.96
GW Pharmaceuticals (GWPH) United Kingdom $3.293B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.073B 0.00
Quidel (QDEL) United States $2.950B 27.99
Aurora Cannabis (ACB) Canada $2.865B 0.00
Agios Pharmaceuticals (AGIO) United States $2.750B 0.00
National Vision Holdings (EYE) United States $2.495B 56.30
Cardiovascular Systems (CSII) United States $1.607B 0.00
Aphria (APHA) $1.384B 0.00
InMode (INMD) Israel $1.242B 0.00
AtriCure (ATRC) United States $1.206B 0.00
VAREX IMAGING (VREX) United States $1.199B 24.01
TG Therapeutics (TGTX) United States $1.006B 0.00
Phibro Animal Health (PAHC) United States $0.969B 18.14
NanoString Technologies (NSTG) United States $0.912B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.820B 31.41
Lantheus Holdings (LNTH) United States $0.795B 19.86
LeMaitre Vascular (LMAT) United States $0.711B 39.98
PetIQ (PETQ) United States $0.695B 16.96
Quanterix (QTRX) United States $0.676B 0.00
Omeros (OMER) United States $0.667B 0.00
HEXO (HEXO) $0.576B 0.00
Cerus (CERS) United States $0.560B 0.00
Surmodics (SRDX) United States $0.552B 57.38
MacroGenics (MGNX) United States $0.518B 0.00
OraSure Technologies (OSUR) United States $0.497B 29.80
Meridian Bioscience (VIVO) United States $0.413B 14.21
Organigram Holdings (OGI) Canada $0.405B 0.00
Utah Medical Products (UTMD) United States $0.396B 28.68
Owens & Minor (OMI) United States $0.346B 12.81
BioLife Solutions (BLFS) United States $0.320B 130.58
Zynex (ZYXI) United States $0.305B 34.48
Bovie Medical (APYX) United States $0.276B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.274B 0.00
United Health Products (UEEC) United States $0.251B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Viemed Healthcare (VMD) United States $0.238B 25.08
Repro-Med Systems (KRMD) United States $0.228B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.172B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Female Health (VERU) United States $0.157B 0.00
Rockwell Medical (RMTI) United States $0.142B 0.00
Cytosorbents (CTSO) United States $0.136B 0.00
Fonar (FONR) United States $0.130B 9.18
MTech Acquisition (KERN) United States $0.128B 0.00
Chimerix (CMRX) United States $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
United-Guardian (UG) United States $0.091B 22.93
Chembio Diagnostics (CEMI) United States $0.078B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.062B 0.00
Surface Oncology (SURF) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00